Cite

1. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107: 130-137. doi: 10.1213/ane.0b013e31816d126810.1213/ane.0b013e31816d126818635478Open DOISearch in Google Scholar

2. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-1103. doi: 10.1111/j.1399-6576.1997.tb04851.x10.1111/j.1399-6576.1997.tb04851.x9366929Open DOISearch in Google Scholar

3. Ledowski T, Hillyard S, O’Dea B, Archer R, Vilas-Boas F, Kyle B. Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. Indian J Anaesth 2013; 57: 46-51. doi: 10.4103/0019-5049.1085622371676610.4103/0019-5049.108562365833523716766Search in Google Scholar

4. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102: 257-26810.1097/00000542-200502000-0000515681938Open DOISearch in Google Scholar

5. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345: e6329. doi: 10.1136/bmj.e632910.1136/bmj.e6329347308823077290Open DOISearch in Google Scholar

6. Fortier LP, McKeen D, Turner K, de Médicis É, Warriner B, Jones PM, et al. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade. Anesth Analg 2015; 121: 366-372. doi: 10.1213/ANE.000000000000075710.1213/ANE.000000000000075725902322Open DOISearch in Google Scholar

7. Kopman AF, Yee PS, Neuman GG. Relationship of the train of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997; 86: 765-771. doi: 10.1097/00000542-199704000-0000510.1097/00000542-199704000-000059105219Open DOISearch in Google Scholar

8. Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg 2006; 102: 426-429. doi: 10.1213/01.ane.0000195543.61123.1f16428537Search in Google Scholar

9. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117: 345-351. doi: 10.1213/ANE.0b013e318299967210.1213/ANE.0b013e318299967223757472Open DOISearch in Google Scholar

10. Nemes R, Fülesdi B, Pongrácz A, Asztalos L, Szabó-Maák Z, Lengyel S, et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. Eur J Anaesthesiol 2017; 34: 609-616. doi: 10.1097/EJA.000000000000058510.1097/EJA.000000000000058528030444Search in Google Scholar

11. Sasaki N, Meyer MJ, Malviya SA, Stanislaus AB, MacDonald T, Doran ME, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology 2014; 121: 959-968. doi: 10.1097/ALN.000000000000044010.1097/ALN.000000000000044025225821Open DOISearch in Google Scholar

12. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007; 98: 302-316. doi: 10.1093/bja/ael38610.1093/bja/ael38617307778Open DOISearch in Google Scholar

13. Cammu GV, Smet V, De Jongh K, Vandeput D. A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery. Anaesth Intensive Care 2012; 40: 999-1006. doi: 10.1177/0310057X120400061110.1177/0310057X120400061123194209Open DOISearch in Google Scholar

14. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109: 389-398. doi: 10.1097/ALN.0b013e318182af3b10.1097/ALN.0b013e318182af3b18719436Open DOISearch in Google Scholar

15. Brueckmann B, Sasaki N, Grobara P, Li MK, Woo T, de Bie J, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth 2015; 115: 743-751. doi: 10.1093/bja/aev10410.1093/bja/aev10425935840Open DOISearch in Google Scholar

16. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115: 946-954. doi: 10.1097/ALN.0b013e318234284010.1097/ALN.0b013e318234284021946094Open DOISearch in Google Scholar

17. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111: 110-119. doi: 10.1213/ANE.0b013e3181c0742810.1213/ANE.0b013e3181c0742819910616Open DOISearch in Google Scholar

18. Della Rocca G, Iannuccelli F, Pompei L, Pietropaoli P, Reale C, Di Marco P. Neuromuscular block in Italy: a survey of current management. Minerva Anestesiol 2012; 78: 767-773Search in Google Scholar

19. Phillips S, Stewart PA, Bilgin AB. A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand. Anaesth Intensive Care 2013; 41: 374-379. doi: 10.1177/0310057X130410031610.1177/0310057X130410031623659401Open DOISearch in Google Scholar

20. Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery: based on a study of 599,548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954; 140: 2-35. doi: 10.1097/00000658-195407000-0000110.1097/00000658-195407000-00001160960013159140Open DOISearch in Google Scholar

21. Ali HH, Kitz RJ. Evaluation of recovery from nondepolarizing neuromuscular block, using a digital neuromuscular transmission analyzer: preliminary report. Anesth Analg 1973; 52: 740-745Search in Google Scholar

22. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-984.10.1097/00000542-200004000-0001410754616Open DOISearch in Google Scholar

23. Tassonyi E. A new concept in the measurement of neuromuscular transmission and block. Anaesthesist 1975; 24: 374-377Search in Google Scholar

24. Waud BE, Waud DR. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block. Anesthesiology 1971; 35: 456-46410.1097/00000542-197111000-000034329144Open DOISearch in Google Scholar

25. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology 2004; 100: 1119-1124. doi: 10.1097/00000542-200405000-0001310.1097/00000542-200405000-0001315114208Search in Google Scholar

26. Viby-Mogensen J, Jensen NH, Engbaek J, Ørding H, Skovgaard LT, Chraemmer-Jørgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985; 63: 440-443. doi: 10.1097/00000542-198510000-0001510.1097/00000542-198510000-000154037404Open DOISearch in Google Scholar

27. Eikermann M, Groeben H, Hüsing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98: 1333-1337. doi: 10.1097/00000542-200306000-0000610.1097/00000542-200306000-0000612766640Open DOISearch in Google Scholar

28. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-1022. doi: 10.1097/ALN.0b013e3181cded0710.1097/ALN.0b013e3181cded0720234315Open DOISearch in Google Scholar

29. Checketts MR, Alladi R, Ferguson K, Gemmell L, Handy JM, Klein AA, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2016; 71: 85-93. doi: 10.1111/anae.1331610.1111/anae.13316506318226582586Open DOISearch in Google Scholar

30. Brull SJ, Kopman AF. Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities. Anesthesiology 2017; 126: 173-190. doi: 10.1097/ALN.000000000000140910.1097/ALN.000000000000140927820709Open DOISearch in Google Scholar

31. Naguib M, Brull SJ, Kopman AF, Hunter JM, Fülesdi B, Arkes HR, et al. Consensus Statement on Perioperative Use of Neuromuscular Monitoring. Anesth Analg 2018; 127: 71-80. doi: 10.1213/ANE.000000000000267010.1213/ANE.000000000000267029200077Open DOISearch in Google Scholar

32. Herbstreit F, Zigrahn D, Ochterbeck C, Peters J, Eikermann M. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2010; 113: 1280-1288. doi: 10.1097/ALN.0b013e3181f70f3d10.1097/ALN.0b013e3181f70f3d20980910Open DOISearch in Google Scholar

eISSN:
2502-0307
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Surgery, Anaesthesiology, Emergency Medicine and Intensive-Care Medicine